Treatment-naïve pemphigus patients showing IgG tissue deposits have serum IgG antibodies against desmoglein 1 detected more often than those against desmoglein 3: a monocentre laboratory experience. [PDF]
Jałowska M +3 more
europepmc +1 more source
Preoperative platelet-lymphocyte ratio and neutrophil-lymphocyte ratio as predictors of occult lymph node metastasis detected using Desmoglein 3 and Cytokeratin in Indian population. [PDF]
Urs AB +5 more
europepmc +1 more source
Up-regulation of ST18 in pemphigus vulgaris drives a self-amplifying p53-dependent pathomechanism resulting in decreased desmoglein 3 expression. [PDF]
Assaf S +8 more
europepmc +1 more source
Evolving Mechanisms in the Pathophysiology of Pemphigus Vulgaris: A Review Emphasizing the Role of Desmoglein 3 in Regulating p53 and the Yes-Associated Protein. [PDF]
Rehman A, Huang Y, Wan H.
europepmc +1 more source
Peripheral tolerance by Treg via constraining OX40 signal in autoreactive T cells against desmoglein 3, a target antigen in pemphigus. [PDF]
Iriki H +15 more
europepmc +1 more source
Caspase-activation powers anti-Desmoglein 3-induced acantholysis in human epidermis. [PDF]
Schmidt MF +10 more
europepmc +2 more sources
Monovalent antibody-conjugated lipid-polymer nanohybrids for active targeting to desmoglein 3 of keratinocytes to attenuate psoriasiform inflammation. [PDF]
Lin ZC +5 more
europepmc +1 more source
Correction: Zakrzewicz et al. Stabilization of Keratinocyte Monolayer Integrity in the Presence of Anti-Desmoglein-3 Antibodies through FcRn Blockade with Efgartigimod: Novel Treatment Paradigm for Pemphigus? Cells 2022, 11, 942. [PDF]
Zakrzewicz A +10 more
europepmc +1 more source

